Simone Di Micco, Tania Ciaglia, Emanuela Salviati, Perrone Michela, Magdalena Kostrzewa, Simona Musella, Aniello Schiano Moriello, Veronica Di Sarno, Gerardina Smaldone, Francesca Di Matteo, Ilaria Capolupo, Rosmara Infantino, Giuseppe Bifulco, Giacomo Pepe, Eduardo M Sommella, Poulami Kumar, Manuela Giovanna Basilicata, Marco Allarà, Nuria Sánchez-Fernández, Ester Aso, Isabel M Gomez-Monterrey, Pietro Campiglia, Carmine Ostacolo, Sabatino Maione, Alessia Ligresti, Alessia Bertamino
The cannabinoid system is one of the most investigated neuromodulatory systems because of its involvement in multiple pathologies such as cancer, inflammation, and psychiatric diseases. Recently, the CB2 receptor has gained increased attention considering its crucial role in modulating neuroinflammation in several pathological conditions like neurodegenerative diseases. Here we describe the rational design of pyrrole-based analogues, which led to a potent and pharmacokinetically suitable CB2 full agonist particularly effective in improving cognitive functions in a scopolamine-induced amnesia murine model...
March 11, 2024: European Journal of Medicinal Chemistry